Standardize your recommendations for endocrine therapy duration using the only guideline-recognized biomarker for prediction of benefit beyond 5 years.1-3
Treating breast cancer is complicated enough — Breast Cancer Index® results are provided in one clear and easy-to-understand report so you and your patients can have an informed and productive conversation about their endocrine treatment plan beyond year 5.
Click the blue number tabs to explore the report.
Use the arrows below the report to switch between a YES result and a NO result.
References: 1. Sgroi DC, et al. J Natl Cancer Inst. 2013;105(14):1036-1042. 2. Bartlett JMS, et al. Clin Cancer Res. DOI: 10.1158/1078-0432.CCR-21-3385. 2022. 3. Noordhoek I, et al. Clin Cancer Res. 2021;27(1):311-319.